Tax withholding trims Inspire Medical (INSP) CEO’s direct share stake

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. CEO and President Herbert Timothy P. Herbert reported a tax-withholding disposition of 1,635 shares of common stock at $59.76 per share. These shares were withheld by the company to satisfy taxes related to the vesting of a restricted stock unit award.

After this transaction, he directly holds 32,686 common shares. An additional 63,658 shares are held indirectly through the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Herbert Timothy P.

Role CEO and President

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,635	$59.76	$98K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 32,686 shares (Direct); Common Stock — 63,658 shares (Indirect, By Trust)

Footnotes (1)

Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Form 4 Insider Transactions: What Each Field Means →

02/18/2026 - 04:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herbert Timothy P.

(Last)

(First)

(Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY

55416

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/13/2026		F		1,635⁽¹⁾	D	$59.76	32,686	D
Common Stock								63,658	I	By Trust⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

2. Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Timothy P. Herbert	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Inspire Medical (INSP) report for its CEO?

Inspire Medical’s CEO reported a tax-withholding disposition of 1,635 common shares. The shares were withheld by the company to cover taxes due on a restricted stock unit vesting, rather than being sold in an open-market transaction.

How many Inspire Medical (INSP) shares did the CEO dispose of for taxes?

The CEO disposed of 1,635 Inspire Medical common shares through tax withholding. These shares were retained by the company to satisfy tax obligations triggered by the vesting of a restricted stock unit award granted to the executive.

What is the CEO’s direct Inspire Medical (INSP) shareholding after the Form 4?

After the reported tax-withholding transaction, the CEO directly owns 32,686 Inspire Medical common shares. This figure reflects his remaining direct stake following the 1,635 shares withheld to cover taxes owed on restricted stock unit vesting.

What indirect Inspire Medical (INSP) holdings are reported for the CEO?

The filing shows 63,658 Inspire Medical common shares held indirectly for the CEO. These shares are owned by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust, as disclosed in the footnotes.

Was the Inspire Medical (INSP) CEO’s transaction an open-market sale?

The transaction was not an open-market sale; it was a tax-withholding disposition. Shares were withheld by Inspire Medical to satisfy tax liabilities from a restricted stock unit vesting, consistent with Form 4 code F for such non-market transactions.

At what price were the Inspire Medical (INSP) shares withheld for taxes?

The 1,635 Inspire Medical common shares involved in the tax-withholding disposition were valued at $59.76 per share. This price is used to calculate the tax liability satisfied when the restricted stock unit award vested for the CEO.